| Cevimeline for the treatment of xerostomia in patients with Sjögren syndrome: a randomized trial. | |
| | |
MedLine Citation:
|
PMID: 12038948 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Cevimeline hydrochloride is a cholinergic agent with muscarinic agonist activity prominently affecting the M1 and M3 receptors prevalent in exocrine glands. We evaluated the safety and efficacy of cevimeline in the treatment of xerostomia in patients with Sjögren syndrome. METHODS: Seventy-five patients with Sjögren syndrome and associated salivary gland dysfunction were enrolled in a double-blind, randomized, placebo-controlled trial at 8 university- and office-based outpatient clinical facilities in the United States. Eligible study participants were randomized to receive 30 mg of cevimeline 3 times daily, 60 mg of cevimeline 3 times daily, or placebo for 6 weeks. Subjective responses were determined using global patient evaluation and visual analog scales. Salivary flow was measured objectively. RESULTS: Sixty-one participants completed the study. Patients in both cevimeline groups had significant improvements in dry mouth, as indicated by symptoms, salivary flow, and use of artificial saliva, compared with the placebo group. The drug was generally well tolerated, with expected adverse events resulting from the drug's muscarinic agonist action. Fourteen patients withdrew from the study because of adverse events, the most frequent being nausea. CONCLUSIONS: Therapy with cevimeline, 30 mg 3 times daily, seems to be well tolerated and to provide substantive relief of xerostomia symptoms. Although both dosages of cevimeline provided symptomatic improvement, 60 mg 3 times daily was associated with an increase in the occurrence of adverse events, particularly gastrointestinal tract disorders. Use of 30 mg of cevimeline provides a new option for the treatment of xerostomia in Sjögren syndrome. |
| | |
Authors:
|
Rose S Fife; Walter F Chase; Robin K Dore; Craig W Wiesenhutter; Peter B Lockhart; Elizabeth Tindall; James Y Suen |
Related Documents
:
|
10487558 - The effect of pilocarpine and biperiden on salivary secretion during and after radiothe... 1608318 - Comparison of antiemetic effect among ephedrine, droperidol and metoclopramide in pedia... 8561338 - Tropisetron for the prevention of postoperative nausea and vomiting in women undergoing... 20537558 - Transdermal scopolamine patch with odansetron for the control of nausea after uterine a... 11994888 - A pilot, randomized, open-label trial assessing safety and pharmakokinetic parameters o... 6406438 - A double-blind comparison of bupropion and amitriptyline in depressed inpatients. |
Publication Detail:
|
Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Archives of internal medicine Volume: 162 ISSN: 0003-9926 ISO Abbreviation: Arch. Intern. Med. Publication Date: 2002 Jun |
Date Detail:
|
Created Date: 2002-05-31 Completed Date: 2002-06-21 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0372440 Medline TA: Arch Intern Med Country: United States |
Other Details:
|
Languages: eng Pagination: 1293-300 Citation Subset: AIM; IM |
Affiliation:
|
Department of Medicine, Indiana University School of Medicine, 535 Barnhill Dr, Room 150, Indianapolis, IN 46202, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Adult Aged Double-Blind Method Female Humans Male Middle Aged Muscarinic Agonists / therapeutic use* Quinuclidines / therapeutic use* Sjogren's Syndrome / complications* Thiophenes* Xerostomia / drug therapy*, etiology |
| Chemical | |
Reg. No./Substance:
|
0/Muscarinic Agonists; 0/Quinuclidines; 0/Thiophenes; 107233-08-9/cevimeline |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Relationship between physical activity and inflammation among apparently healthy middle-aged and old...
Next Document: A randomized trial comparing intensive and passive education in patients with diabetes mellitus.